Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

X-SITE CE-marks vascular closure system

This article was originally published in Clinica

Executive Summary

X-SITE Medical has CE-marked for sale in Europe its suture-based device for sealing arterial access sites following catheterisation procedures. The X-PRESS vascular closure system, which the company claims can permit early ambulation after catheterisation, works by percutaneously delivering single or multiple loops of suture across the arterial puncture. The Blue Bell, Pennsylvania company also says that it has completed a pilot study of the device in the US and has been cleared to start randomised clinical trials.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069898

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel